Invest in Sen-Jam Pharmaceutical

Impacting billions by fighting inflammation at the source

EARLY BIRD TERMS: $760,333 LEFT

$2,094,667

raised from 690 investors

INVEST

min $250

INVESTMENT TERMS

Convertible Note

$100M $80M valuation cap

Early Bird Bonus: The first $2.5M of investments will be in a convertible note with a $80M valuation cap and 20% discount

$250, $1K, $5K, $10K, $25K, $50K, $100K

Pitch Video

Investor Panel

sen-jam.com

Huntington, New York

Technology Notable Angel Female Founder B2B Healthcare

Investor Panel

interviewed Sen-Jam Pharmaceutical. Play Video

What Investors Say

LEAD INVESTOR

Invested $30,000 this round + $135,000 previously

Sen-Jam's therapeutic approach could potentially revolutionize the cost effective treatment of significant maladies that affect millions of people. The company brings together three core investment priorities for me: 1) finding early stage companies with significant upside potential: 2) leveraging the talents of experienced entrepreneurial management; 3) making a meaningful difference in the world. Since my first investment in Sen-Jam, I've been impressed by how much they've accomplished with limited resources, and by the commitment and excellent communication of the founders. It has instilled enough confidence for me to increase my investment by over 20% this time.